{"instruction": "你是专门进行事件提取的专家。请从input中抽取出符合schema定义的事件，不存在的事件返回空列表，不存在的论元返回NAN，如果论元存在多值请返回列表。请按照JSON字符串的格式回答。", "schema": [{"event_type": "股东减持", "trigger": true, "arguments": ["交易金额", "减持方", "交易股票/股份数量", "交易完成时间", "减持部分占总股本比例"]}, {"event_type": "亏损", "trigger": true, "arguments": ["公司名称", "财报周期", "披露时间", "净亏损", "亏损变化"]}, {"event_type": "企业融资", "trigger": true, "arguments": ["被投资方", "融资轮次", "融资金额", "事件时间"]}, {"event_type": "中标", "trigger": true, "arguments": ["中标标的", "中标日期", "中标金额", "中标公司", "招标方", "披露日期"]}], "input": "公告精选：永兴材料研发成功替代进口用高温合金材料 多家药企拟中标药品集中采购\n原标题：公告精选：永兴材料(14.160,0.00,0.00%)研发成功替代进口用高温合金材料 多家药企拟中标药品集中采购    来源：证券时报·e公司\n亚联发展(11.260,1.02,9.96%)两连涨停：未从事数字货币的相关研发；永兴材料：替代进口用GH2132高温合金材料研发成功；广生堂(41.100,2.87,7.51%)：公司药品恩替卡韦胶囊拟中标联盟地区药品集中采购；京新药业(11.850,-1.32,-10.02%)：左乙拉西坦片、头孢呋辛酯片中标联盟地区药品集中采购；普洛药业(11.750,-0.20,-1.67%)：左乙拉西坦片拟中选联盟地区集中采购；华钰矿业(9.890,0.02,0.20%)：股东西藏博实协议转让公司15%股份；圆通速递(11.600,-0.27,-2.27%)：20.38亿股限售股9月30日上市流通占总股本71%。"}
{"股东减持": [], "亏损": [], "企业融资": [], "中标": [{"trigger": "中标", "arguments": {"中标标的": "恩替卡韦胶囊", "中标日期": "NAN", "中标金额": "NAN", "中标公司": "广生堂", "招标方": "NAN", "披露日期": "NAN"}}, {"trigger": "中标", "arguments": {"中标标的": ["头孢呋辛酯片", "左乙拉西坦片"], "中标日期": "NAN", "中标金额": "NAN", "中标公司": "京新药业", "招标方": "NAN", "披露日期": "NAN"}}, {"trigger": "中选", "arguments": {"中标标的": "左乙拉西坦片", "中标日期": "NAN", "中标金额": "NAN", "中标公司": "普洛药业", "招标方": "NAN", "披露日期": "NAN"}}]}